
zzso chronic zzso disease zzso cases is required to estimate COPD zzso to enroll COPD zzso and to estimate air pollution health zzso zzso health data are frequently used to identify COPD cases, though their zzso has not been zzso zzso This paper aims to assess the contribution of pharmaceutical data in detecting COPD cases and to estimate the reliability of zzso databases in detecting COPD zzso zzso COPD cases among zzso were estimated in four Italian areas in 2006 from zzso zzso and adding pharmaceutical zzso zzso and zzso prevalence rates were calculated in each zzso Internal zzso of COPD diagnoses from hospital and mortality databases was zzso zzso database was used to confirm the zzso COPD cases and to examine the selection and zzso of hospitalized zzso zzso zzso between COPD and asthma cases was estimated using hospital zzso zzso COPD cases were zzso from zzso zzso zzso when respiratory prescriptions were zzso zzso ranged from zzso Only zzso of pharmaceutical COPD cases were hospitalized or died and only zzso of zzso cases consumed respiratory zzso this last proportion increased to zzso among the older cases with a principal zzso COPD cases with a contemporary asthma diagnosis were zzso We found that pharmaceutical data increases COPD prevalence estimates zzso zzso zzso does not necessarily indicate COPD severity, COPD as a principal diagnosis confirmed with medicine prescription more likely represented true zzso zzso affects asthma cases to greater extent than COPD zzso 

